Mehdi Ali, Rabbani Shafaat A
Department of Human Genetics, McGill University, Montreal, QC H3A 2B4, Canada.
Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Cancers (Basel). 2021 Feb 1;13(3):545. doi: 10.3390/cancers13030545.
DNA and RNA methylation play a vital role in the transcriptional regulation of various cell types including the differentiation and function of immune cells involved in pro- and anti-cancer immunity. Interactions of tumor and immune cells in the tumor microenvironment (TME) are complex. TME shapes the fate of tumors by modulating the dynamic DNA (and RNA) methylation patterns of these immune cells to alter their differentiation into pro-cancer (e.g., regulatory T cells) or anti-cancer (e.g., CD8+ T cells) cell types. This review considers the role of DNA and RNA methylation in myeloid and lymphoid cells in the activation, differentiation, and function that control the innate and adaptive immune responses in cancer and non-cancer contexts. Understanding the complex transcriptional regulation modulating differentiation and function of immune cells can help identify and validate therapeutic targets aimed at targeting DNA and RNA methylation to reduce cancer-associated morbidity and mortality.
DNA和RNA甲基化在多种细胞类型的转录调控中发挥着至关重要的作用,包括参与促癌和抗癌免疫的免疫细胞的分化和功能。肿瘤微环境(TME)中肿瘤细胞与免疫细胞的相互作用十分复杂。TME通过调节这些免疫细胞动态的DNA(和RNA)甲基化模式来塑造肿瘤的命运,从而改变它们分化为促癌(如调节性T细胞)或抗癌(如CD8+ T细胞)细胞类型。本综述探讨了DNA和RNA甲基化在髓系和淋巴细胞中的作用,这些细胞在癌症和非癌症背景下控制先天免疫和适应性免疫反应的激活、分化及功能。了解调节免疫细胞分化和功能的复杂转录调控,有助于识别和验证旨在靶向DNA和RNA甲基化的治疗靶点,以降低癌症相关的发病率和死亡率。